Candida albicans shaving to profile human serum proteins on hyphal surface

Frontiers in Microbiology

Volumn 6, Issue DEC, 2015, Pages

  Marín, Elvira ^a   Parra Giraldo, Claudia M ^a,c   Hernández Haro, Carolina ^a   Hernáez, María L ^a   Nombela, César ^a,b,d   Monteoliva, Lucía ^a,b   Gil, Concha ^a,b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b INSTITUTO RAMÓN Y CAJAL DE INVESTIGACIÓN SANITARIA IRYCIS   (Spain)

^c PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^d UNIVERSIDAD INTERNACIONAL MENÉNDEZ PELAYO   (Spain)

Author keywords

Candida albicans; Coagulation pathways; Complement pathways; GPI anchored proteins; Host pathogen interaction; Human serum; Shaving; Surface proteins

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; APOLIPOPROTEIN; COMPLEMENT COMPONENT C3; CYTOSKELETON PROTEIN; FICOLIN; PLASMA PROTEIN; SERPINA5 PROTEIN; SERPINA6 PROTEIN; SERPIND1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELL MEMBRANE PERMEABILITY; COMPLEMENT ACTIVATION; COMPLEMENT CLASSICAL PATHWAY; CONFOCAL LASER MICROSCOPY; EPIFLUORESCENCE MICROSCOPY; FLOW CYTOMETRY; FUNGAL CELL CULTURE; FUNGUS GROWTH; FUNGUS HYPHAE; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOGENICITY; PROTEIN INTERACTION; PROTEOMICS;

EID: 84953884167     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.01343     Document Type: Article

References (86)

1. Almirante, B., Rodríguez, D., Park, B. J., Cuenca-Estrella, M., Planes, A. M., Almela, M., et al. (2005). Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J. Clin. Microbiol. 43, 1829-1835. doi: 10.1128/JCM.43.4.1829-1835.2005
2. Amara, U., Flierl, M. A., Rittirsch, D., Klos, A., Chen, H., Acker, B., et al. (2010). Molecular intercommunication between the complement and coagulation systems. J. Immunol. 185, 5628-5636. doi: 10.4049/jimmunol.0903678
3. Amara, U., Rittirsch, D., Flierl, M., Bruckner, U., Klos, A., Gebhard, F., et al. (2008). Interaction between the coagulation and complement system. Adv. Exp. Med. Biol. 632, 71-79. doi: 10.1007/978-0-387-78952-1_6
4. Anderson, N. L., and Anderson, N. G. (2002). The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 1, 845-867. doi: 10.1074/mcp.R200007-MCP200
5. Barthel, D., Schindler, S., and Zipfel, P. F. (2012). Plasminogen is a complement inhibitor. J. Biol. Chem. 287, 18831-18842. doi: 10.1074/jbc.M111.323287
6. Brown, G. D., Denning, D. W., Gow, N. A., Levitz, S. M., Netea, M. G., and White, T. C. (2012). Hidden killers: human fungal infections. Sci. Transl. Med. 4, 165rv113. doi: 10.1126/scitranslmed.3004404
7. Buu, L. M., and Chen, Y. C. (2014). Impact of glucose levels on expression of hypha-associated secreted aspartyl proteinases in Candida albicans. J. Biomed. Sci. 21:22. doi: 10.1186/1423-0127-21-22
8. Collette, J. R., and Lorenz, M. C. (2011). Mechanisms of immune evasion in fungal pathogens. Curr. Opin. Microbiol. 14, 668-675. doi: 10.1016/j.mib.2011.09.007
9. Crowe, J. D., Sievwright, I. K., Auld, G. C., Moore, N. R., Gow, N. A., and Booth, N. A. (2003). Candida albicans binds human plasminogen: identification of eight plasminogen-binding proteins. Mol. Microbiol. 47, 1637-1651. doi: 10.1046/j.1365-2958.2003.03390.x
10. Chaffin, W. L. (2008). Candida albicans cell wall proteins. Microbiol. Mol. Biol. Rev. 72, 495-544. doi: 10.1128/MMBR.00032-07
11. Chauhan, A. K., and Moore, T. L. (2006). Presence of plasma complement regulatory proteins clusterin (Apo J) and vitronectin (S40) on circulating immune complexes (CIC). Clin. Exp. Immunol. 145, 398-406. doi: 10.1111/j.1365-2249.2006.03135.x
12. de Bont, N., Netea, M. G., Demacker, P. N., Kullberg, B. J., van der Meer, J. W., and Stalenhoef, A. F. (2000). Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae. Eur. J. Clin. Invest. 30, 818-822. doi: 10.1046/j.1365-2362.2000.00715.x
13. de Groot, P. W., Bader, O., de Boer, A. D., Weig, M., and Chauhan, N. (2013). Adhesins in human fungal pathogens: glue with plenty of stick. Eukaryotic Cell 12, 470-481. doi: 10.1128/EC.00364-12
14. De Groot, P. W., Hellingwerf, K. J., and Klis, F. M. (2003). Genome-wide identification of fungal GPI proteins. Yeast 20, 781-796. doi: 10.1002/yea.1007
15. Diamond, S. L. (2013). Systems biology of coagulation. J. Thromb. Haemost 11 (Suppl. 1), 224-232. doi: 10.1111/jth.12220
16. Dreisbach, A., van der Kooi-Pol, M. M., Otto, A., Gronau, K., Bonarius, H. P., Westra, H., et al. (2011). Surface shaving as a versatile tool to profile global interactions between human serum proteins and the Staphylococcus aureus cell surface. Proteomics 11, 2921-2930. doi: 10.1002/pmic.201100134
17. Dühring, S., Germerodt, S., Skerka, C., Zipfel, P. F., Dandekar, T., and Schuster, S. (2015). Host-pathogen interactions between the human innate immune system and Candida albicans-Understanding and modeling defense and evasion strategies. Front. Microbiol. 6:625. doi: 10.3389/fmicb.2015.00625
18. Ene, I. V., Brunke, S., Brown, A. J., and Hube, B. (2014). Metabolism in Fungal Pathogenesis. Cold Spring Harb. Perspect. Med. 4. doi: 10.1101/cshperspect.a019695
19. Engleberg, N. C., Dermody, T. S., and DiRita, V. (eds.). (2012). "Innate immunity" in Schaechter's Mechanisms of Microbial Disease (Philadelphia, PA: Lippincott Williams & Wilkins), 66-90.
20. Fan, Y., He, H., Dong, Y., and Pan, H. (2013). Hyphae-specific genes HGC1, ALS3, HWP1, and ECE1 and relevant signaling pathways in Candida albicans. Mycopathologia 176, 329-335. doi: 10.1007/s11046-013-9684-6
21. Fradin, C., Kretschmar, M., Nichterlein, T., Gaillardin, C., d'enfert, C., and Hube, B. (2003). Stage-specific gene expression of Candida albicans in human blood. Mol. Microbiol. 47, 1523-1543. doi: 10.1046/j.1365-2958.2003.03396.x
22. Gadjeva, M., Dodds, A. W., Taniguchi-Sidle, A., Willis, A. C., Isenman, D. E., and Law, S. K. (1998). The covalent binding reaction of complement component C3. J. Immunol. 161, 985-990.
23. Gil-Bona, A., Parra-Giraldo, C. M., Hernáez, M. L., Reales-Calderon, J. A., Solis, N. V., Filler, S. G., et al. (2015). Candida albicans cell shaving uncovers new proteins involved in cell wall integrity, yeast to hypha transition, stress response and host-pathogen interaction. J. Proteomics 127(Pt B), 340-351. doi: 10.1016/j.jprot.2015.06.006
24. Gillum, A. M., Tsay, E. Y., and Kirsch, D. R. (1984). Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol. Gen. Genet. 198, 179-182. doi: 10.1007/BF00328721
25. Gozalbo, D., Gil-Navarro, I., Azorín, I., Renau-Piqueras, J., Martínez, J. P., and Gil, M. L. (1998). The cell wall-associated glyceraldehyde-3-phosphate dehydrogenase of Candida albicans is also a fibronectin and laminin binding protein. Infect. Immun. 66, 2052-2059.
26. Green, J. V., Orsborn, K. I., Zhang, M., Tan, Q. K., Greis, K. D., Porollo, A., et al. (2013). Heparin-binding motifs and biofilm formation by Candida albicans. J. Infect. Dis. 208, 1695-1704. doi: 10.1093/infdis/jit391
27. Grunfeld, C., and Feingold, K. R. (2008). HDL and innate immunity: a tale of two apolipoproteins. J. Lipid Res. 49, 1605-1606. doi: 10.1194/jlr.E800011-JLR200
28. Heilmann, C. J., Sorgo, A. G., Siliakus, A. R., Dekker, H. L., Brul, S., de Koster, C. G., et al. (2011). Hyphal induction in the human fungal pathogen Candida albicans reveals a characteristic wall protein profile. Microbiology 157, 2297-2307. doi: 10.1099/mic.0.049395-0
29. Hernáez, M. L., Ximénez-Embún, P., Martínez-Gomariz, M., Gutiérrez-Blázquez, M. D., Nombela, C., and Gil, C. (2010). Identification of Candida albicans exposed surface proteins in vivo by a rapid proteomic approach. J. Proteomics 73, 1404-1409. doi: 10.1016/j.jprot.2010.02.008
30. Hube, B. (2006). Infection-associated genes of Candida albicans. Future Microbiol. 1, 209-218. doi: 10.2217/17460913.1.2.209
31. Inglis, D. O., Arnaud, M. B., Binkley, J., Shah, P., Skrzypek, M. S., Wymore, F., et al. (2012). The Candida genome database incorporates multiple Candida species: multispecies search and analysis tools with curated gene and protein information for Candida albicans and Candida glabrata. Nucleic Acids Res. 40, D667-D674. doi: 10.1093/nar/gkr945
32. Insenser, M. R., Hernáez, M. L., Nombela, C., Molina, M., Molero, G., and Gil, C. (2010). Gel and gel-free proteomics to identify Saccharomyces cerevisiae cell surface proteins. J. Proteomics 73, 1183-1195. doi: 10.1016/j.jprot.2010.02.005
33. Jiang, H., Wagner, E., Zhang, H., and Frank, M. M. (2001). Complement 1 inhibitor is a regulator of the alternative complement pathway. J. Exp. Med. 194, 1609-1616. doi: 10.1084/jem.194.11.1609
34. Jong, A. Y., Chen, S. H., Stins, M. F., Kim, K. S., Tuan, T. L., and Huang, S. H. (2003). Binding of Candida albicans enolase to plasmin(ogen) results in enhanced invasion of human brain microvascular endothelial cells. J. Med. Microbiol. 52, 615-622. doi: 10.1099/jmm.0.05060-0
35. Joo, M. Y., Shin, J. H., Jang, H. C., Song, E. S., Kee, S. J., Shin, M. G., et al. (2013). Expression of SAP5 and SAP9 in Candida albicans biofilms: comparison of bloodstream isolates with isolates from other sources. Med. Mycol. 51, 892-896. doi: 10.3109/13693786.2013.824623
36. Karkowska-Kuleta, J., Rapala-Kozik, M., and Kozik, A. (2009). Fungi pathogenic to humans: molecular bases of virulence of Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus. Acta Biochim. Pol. 56, 211-224.
37. Kazatchkine, M. D., and Jouvin, M. H. (1984). Interactions between the alternative complement pathway and proteases of the coagulation system. Adv. Exp. Med. Biol. 167, 235-239. doi: 10.1007/978-1-4615-9355-3_19
38. Klis, F. M., Sosinska, G. J., de Groot, P. W., and Brul, S. (2009). Covalently linked cell wall proteins of Candida albicans and their role in fitness and virulence. FEMS Yeast Res. 9, 1013-1028. doi: 10.1111/j.1567-1364.2009.00541.x
39. Kretschmar, M., Felk, A., Staib, P., Schaller, M., Hess, D., Callapina, M., et al. (2002). Individual acid aspartic proteinases (Saps) 1-6 of Candida albicans are not essential for invasion and colonization of the gastrointestinal tract in mice. Microb. Pathog. 32, 61-70. doi: 10.1006/mpat.2001.0478
40. Kumamoto, C. A., and Vinces, M. D. (2005). Contributions of hyphae and hypha-co-regulated genes to Candida albicans virulence. Cell. Microbiol. 7, 1546-1554. doi: 10.1111/j.1462-5822.2005.00616.x
41. Law, R. H., Zhang, Q., McGowan, S., Buckle, A. M., Silverman, G. A., Wong, W., et al. (2006). An overview of the serpin superfamily. Genome Biol. 7, 216. doi: 10.1186/gb-2006-7-5-216
42. Lee, K. L., Buckley, H. R., and Campbell, C. C. (1975). An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida albicans. Sabouraudia 13, 148-153. doi: 10.1080/00362177585190271
43. Leleu, G., Aegerter, P., and Guidet, B. (2002). Systemic candidiasis in intensive care units: a multicenter, matched-cohort study. J. Crit. Care 17, 168-175. doi: 10.1053/jcrc.2002.35815
44. Lesiak-Markowicz, I., Vogl, G., Schwarzmuller, T., Speth, C., Lass-Flörl, C., Dierich, M. P., et al. (2011). Candida albicans Hgt1p, a multifunctional evasion molecule: complement inhibitor, CR3 analogue, and human immunodeficiency virus-binding molecule. J. Infect. Dis. 204, 802-809. doi: 10.1093/infdis/jir455
45. Lu, Y., Su, C., and Liu, H. (2014). Candida albicans hyphal initiation and elongation. Trends Microbiol. 22, 707-714. doi: 10.1016/j.tim.2014.09.001
46. Luo, S., Blom, A. M., Rupp, S., Hipler, U. C., Hube, B., Skerka, C., et al. (2011). The pH-regulated antigen 1 of Candida albicans binds the human complement inhibitor C4b-binding protein and mediates fungal complement evasion. J. Biol. Chem. 286, 8021-8029. doi: 10.1074/jbc.M110.130138
47. Luo, S., Hoffmann, R., Skerka, C., and Zipfel, P. F. (2013). Glycerol-3-phosphate dehydrogenase 2 is a novel factor H-, factor H-like protein 1-, and plasminogen-binding surface protein of Candida albicans. J. Infect. Dis. 207, 594-603. doi: 10.1093/infdis/jis718
48. Luo, S., Poltermann, S., Kunert, A., Rupp, S., and Zipfel, P. F. (2009). Immune evasion of the human pathogenic yeast Candida albicans: Pra1 is a Factor H, FHL-1 and plasminogen binding surface protein. Mol. Immunol. 47, 541-550. doi: 10.1016/j.molimm.2009.07.017
49. Mayer, F. L., Wilson, D., and Hube, B. (2013). Candida albicans pathogenicity mechanisms. Virulence 4, 119-128. doi: 10.4161/viru.22913
50. Meri, T., Blom, A. M., Hartmann, A., Lenk, D., Meri, S., and Zipfel, P. F. (2004). The hyphal and yeast forms of Candida albicans bind the complement regulator C4b-binding protein. Infect. Immun. 72, 6633-6641. doi: 10.1128/IAI.72.11.6633-6641.2004
51. Mitchell, P. (2010). Proteomics retrenches. Nat. Biotechnol. 28, 665-670. doi: 10.1038/nbt0710-665
52. Mochon, A. B., Jin, Y., Kayala, M. A., Wingard, J. R., Clancy, C. J., Nguyen, M. H., et al. (2010). Serological profiling of a Candida albicans protein microarray reveals permanent host-pathogen interplay and stage-specific responses during candidemia. PLoS Pathog. 6:e1000827. doi: 10.1371/annotation/eff399e1-51e0-43b1-bdf4-1a11e9ada9bd
53. Monniot, C., Boisramé, A., Da Costa, G., Chauvel, M., Sautour, M., Bougnoux, M. E., et al. (2013). Rbt1 protein domains analysis in Candida albicans brings insights into hyphal surface modifications and Rbt1 potential role during adhesion and biofilm formation. PLoS ONE 8:e82395. doi: 10.1371/journal.pone.0082395
54. Naglik, J. R., Challacombe, S. J., and Hube, B. (2003). Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol. Mol. Biol. Rev. 67, 400-428. doi: 10.1128/MMBR.67.3.400-428.2003
55. Nanjappa, V., Thomas, J. K., Marimuthu, A., Muthusamy, B., Radhakrishnan, A., Sharma, R., et al. (2014). Plasma Proteome Database as a resource for proteomics research: 2014 update. Nucleic Acids Res. 42, D959-D965. doi: 10.1093/nar/gkt1251
56. Nielsen, E. W., Johansen, H. T., Høgåsen, K., Wuillemin, W., Hack, C. E., and Mollnes, T. E. (1996). Activation of the complement, coagulation, fibrinolytic and kallikrein-kinin systems during attacks of hereditary angioedema. Scand. J. Immunol. 44, 185-192. doi: 10.1046/j.1365-3083.1996.d01-298.x
57. Nombela, C., Gil, C., and Chaffin, W. L. (2006). Non-conventional protein secretion in yeast. Trends Microbiol. 14, 15-21. doi: 10.1016/j.tim.2005.11.009
58. Pardo, M., Monteoliva, L., Vázquez, P., Martínez, R., Molero, G., Nombela, C., et al. (2004). PST1 and ECM33 encode two yeast cell surface GPI proteins important for cell wall integrity. Microbiology 150, 4157-4170. doi: 10.1099/mic.0.26924-0
59. Paréj, K., Dobó, J., Závodszky, P., and Gál, P. (2013). The control of the complement lectin pathway activation revisited: both C1-inhibitor and antithrombin are likely physiological inhibitors, while alpha2-macroglobulin is not. Mol. Immunol. 54, 415-422. doi: 10.1016/j.molimm.2013.01.009
60. Peerschke, E. I., Yin, W., and Ghebrehiwet, B. (2008). Platelet mediated complement activation. Adv. Exp. Med. Biol. 632, 81-91. doi: 10.1007/978-0-387-78952-1_7
61. Pitarch, A., Abian, J., Carrascal, M., Sánchez, M., Nombela, C., and Gil, C. (2004). Proteomics-based identification of novel Candida albicans antigens for diagnosis of systemic candidiasis in patients with underlying hematological malignancies. Proteomics 4, 3084-3106. doi: 10.1002/pmic.200400903
62. Pitarch, A., Jiménez, A., Nombela, C., and Gil, C. (2006). Decoding serological response to Candida cell wall immunome into novel diagnostic, prognostic, and therapeutic candidates for systemic candidiasis by proteomic and bioinformatic analyses. Mol. Cell. Proteomics 5, 79-96. doi: 10.1074/mcp.M500243-MCP200
63. Pitarch, A., Jiménez, A., Nombela, C., and Gil, C. (2008). Serological proteome analysis to identify systemic candidiasis patients in the intensive care unit: analytical, diagnostic and prognostic validation of anti-Candida enolase antibodies on quantitative clinical platforms. Proteomics Clin. Appl. 2, 596-618. doi: 10.1002/prca.200780039
64. Pitarch, A., Nombela, C., and Gil, C. (2011). Prediction of the clinical outcome in invasive candidiasis patients based on molecular fingerprints of five anti-Candida antibodies in serum. Mol. Cell. Proteomics 10:M110.004010. doi: 10.1074/mcp.M110.004010
65. Poltermann, S., Kunert, A., von der Heide, M., Eck, R., Hartmann, A., and Zipfel, P. F. (2007). Gpm1p is a factor H-, FHL-1-, and plasminogen-binding surface protein of Candida albicans. J. Biol. Chem. 282, 37537-37544. doi: 10.1074/jbc.M707280200
66. Ragni, E., Calderon, J., Fascio, U., Sipiczki, M., Fonzi, W. A., and Popolo, L. (2011). Phr1p, a glycosylphosphatidylinsitol-anchored beta(1, 3)-glucanosyltransferase critical for hyphal wall formation, localizes to the apical growth sites and septa in Candida albicans. Fungal Genet. Biol. 48, 793-805. doi: 10.1016/j.fgb.2011.05.003
67. Rittirsch, D., Flierl, M. A., and Ward, P. A. (2008). Harmful molecular mechanisms in sepsis. Nat. Rev. Immunol. 8, 776-787. doi: 10.1038/nri2402
68. Rodríguez de Córdoba, S., Esparza-Gordillo, J., Goicoechea de Jorge, E., Lopez-Trascasa, M., and Sánchez-Corral, P. (2004). The human complement factor H: functional roles, genetic variations and disease associations. Mol. Immunol. 41, 355-367. doi: 10.1016/j.molimm.2004.02.005
69. Sjöholm, K., Karlsson, C., Linder, A., and Malmström, J. (2014). A comprehensive analysis of the Streptococcus pyogenes and human plasma protein interaction network. Mol. Biosyst. 10, 1698-1708. doi: 10.1039/C3MB70555B
70. Soares, R. M., de Soares, A. R. M., Alviano, D. S., Angluster, J., Alviano, C. S., and Travassos, L. R. (2000). Identification of sialic acids on the cell surface of Candida albicans. Biochim. Biophys. Acta 1474, 262-268. doi: 10.1016/S0304-4165(00)00003-9
71. Soltis, R. D., Hasz, D., Morris, M. J., and Wilson, I. D. (1979). Studies on the nature of heat-labile anti-complementary activity in normal human serum. Clin. Exp. Immunol. 37, 310-322.
72. Sonesson, A., Ringstad, L., Nordahl, E. A., Malmsten, M., Mörgelin, M., and Schmidtchen, A. (2007). Antifungal activity of C3a and C3a-derived peptides against Candida. Biochim. Biophys. Acta 1768, 346-353. doi: 10.1016/j.bbamem.2006.10.017
73. Sosinska, G. J., de Koning, L. J., de Groot, P. W., Manders, E. M., Dekker, H. L., Hellingwerf, K. J., et al. (2011). Mass spectrometric quantification of the adaptations in the wall proteome of Candida albicans in response to ambient pH. Microbiology 157, 136-146. doi: 10.1099/mic.0.044206-0
74. Sudbery, P. E. (2011). Growth of Candida albicans hyphae. Nat. Rev. Microbiol. 9, 737-748. doi: 10.1038/nrmicro2636
75. Uniprot, C. (2014). Activities at the Universal Protein Resource (UniProt). Nucleic Acids Res. 42, D191-D198. doi: 10.1093/nar/gkt1140
76. Urban, C., Xiong, X., Sohn, K., Schröppel, K., Brunner, H., and Rupp, S. (2005). The moonlighting protein Tsa1p is implicated in oxidative stress response and in cell wall biogenesis in Candida albicans. Mol. Microbiol. 57, 1318-1341. doi: 10.1111/j.1365-2958.2005.04771.x
77. Verschoor, A., and Langer, H. F. (2013). Crosstalk between platelets and the complement system in immune protection and disease. Thromb. Haemost. 110, 910-919. doi: 10.1160/TH13-02-0102
78. Vialas, V., Sun, Z., Loureiro Y Penha, C. V., Carrascal, M., Abián, J., Monteoliva, L., et al. (2014). A Candida albicans PeptideAtlas. J. Proteomics 97, 62-68. doi: 10.1016/j.jprot.2013.06.020
79. Viudes, A., Pemán, J., Cantón, E., Ubeda, P., López-Ribot, J. L., and Gobernado, M. (2002). Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur. J. Clin. Microbiol. Infect. Dis. 21, 767-774. doi: 10.1007/s10096-002-0822-1
80. Vonk, A. G., De Bont, N., Netea, M. G., Demacker, P. N., van der Meer, J. W., Stalenhoef, A. F., et al. (2004). Apolipoprotein-E-deficient mice exhibit an increased susceptibility to disseminated candidiasis. Med. Mycol. 42, 341-348. doi: 10.1080/13693780410001657135
81. Walport, M. J. (2001a). Complement. First of two parts. N. Engl. J. Med. 344, 1058-1066. doi: 10.1056/NEJM200104053441406
82. Walport, M. J. (2001b). Complement. Second of two parts. N. Engl. J. Med. 344, 1140-1144. doi: 10.1056/NEJM200104123441506
83. Wilson, L. S., Reyes, C. M., Stolpman, M., Speckman, J., Allen, K., and Beney, J. (2002). The direct cost and incidence of systemic fungal infections. Value Health 5, 26-34. doi: 10.1046/j.1524-4733.2002.51108.x
84. Yan, L., Yang, C., and Tang, J. (2013). Disruption of the intestinal mucosal barrier in Candida albicans infections. Microbiol. Res. 168, 389-395. doi: 10.1016/j.micres.2013.02.008
85. Zipfel, P. F., Skerka, C., Kupka, D., and Luo, S. (2011). Immune escape of the human facultative pathogenic yeast Candida albicans: the many faces of the Candida Pra1 protein. Int. J. Med. Microbiol. 301, 423-430. doi: 10.1016/j.ijmm.2011.04.010
86. Zybailov, B. L., Florens, L., and Washburn, M. P. (2007). Quantitative shotgun proteomics using a protease with broad specificity and normalized spectral abundance factors. Mol. Biosyst. 3, 354-360. doi: 10.1039/b701483j